BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  ASCO15: Clovis Oncology’s Rociletinib (CO-1686) Phase II Study Results Demonstrate Consistent And Promising Clinical Activity And Disease Control In Very Advanced Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC

  June 1, 2015

   · 

  11 min read
• Drug Development

  ASCO15: AbbVie Presents Phase 2 Results From Study Of Investigational Medicine Veliparib In Patients With Non-Small Cell Lung Cancer At The American Society Of Clinical Oncology Annual Meeting

  June 1, 2015

   · 

  8 min read
• Drug Development

  Pharmacyclics Release: Phase III HELIOS Study Results Show Ibrutinib (IMBRUVICA) Combination Therapy Significantly Increased Progression-Free Survival In Previously-Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients

  June 1, 2015

   · 

  15 min read
• Drug Development

  Janssen Research & Development Release: Ibrutinib (IMBRUVICA) HELIOS Interim Analysis Study Data Show Significant Reductions In Risk Of Progression Or Death In Patients With Previously-Treated Chronic Lymphocytic Leukemia

  June 1, 2015

   · 

  13 min read
• Drug Development

  Janssen Research & Development Release: Data Show Daratumumab Achieved a Pronounced Overall Response Rate As A Single-Agent With Tolerable Safety Profile In Heavily Pre-Treated Multiple Myeloma Patients

  June 1, 2015

   · 

  9 min read
• Drug Development

  ASCO15: Results From Phase 2 Study Of Lenvatinib When Combined With Everolimus In Metastatic Renal Cell Carcinoma To Be Presented In Oral Session At ASCO

  June 1, 2015

   · 

  9 min read
• Drug Development

  ASCO15: Esperance Pharmaceuticals, Inc. Reports Positive EP-100 Phase Ll Results In Ovarian Cancer At 2015 ASCO Annual Meeting

  June 1, 2015

   · 

  3 min read
• BioMidwest

  St. Jude Children’s Research Hospital Release: Study Finds Changes In Treatment Have Increased Life Span For Childhood Cancer Survivors

  June 1, 2015

   · 

  5 min read
• Deals

  Actavis Completes Acquisition Of Auden Mckenzie

  June 1, 2015

   · 

  3 min read
• Drug Development

  Mirati Therapeutics Release: Initial Data From Ongoing Expansion Study Of MGCD265 Show Preliminary Evidence Of Clinical Efficacy In Heavily Pretreated Non-Small Cell Lung Cancer (NSCLC) Patients With MET Gene Alterations

  June 1, 2015

   · 

  15 min read